Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 4.89%1.43B | 1.19%906.7M | 0.34%406.31M | 60.03%1.8B | 78.13%1.37B | 91.22%896.02M | 98.52%404.93M | 21.87%1.13B | 0.45%767.14M | -17.71%468.57M |
| Operating revenue | 4.89%1.43B | 1.19%906.7M | 0.34%406.31M | 60.03%1.8B | 78.13%1.37B | 91.22%896.02M | 98.52%404.93M | 21.87%1.13B | 0.45%767.14M | -17.71%468.57M |
| Total operating cost | 16.43%1.34B | 13.15%842.46M | 10.30%379.85M | 39.33%1.54B | 47.20%1.15B | 50.73%744.56M | 57.09%344.39M | 33.71%1.11B | 20.09%781.5M | 8.24%493.98M |
| Operating cost | 10.24%1B | 5.34%625.4M | 0.85%278.52M | 40.45%1.2B | 53.46%910.56M | 59.51%593.67M | 73.94%276.16M | 31.53%853.3M | 12.81%593.35M | -2.43%372.17M |
| Operating tax surcharges | 72.00%3.34M | 44.10%1.76M | 6.33%623.16K | 19.47%2.84M | 12.68%1.94M | 388.12%1.22M | 451.45%586.08K | 111.92%2.37M | 113.45%1.72M | -60.74%249.9K |
| Operating expense | 47.94%56.48M | 51.19%37.67M | 47.75%17.7M | 43.59%57.14M | 30.96%38.18M | 26.32%24.92M | 32.59%11.98M | 43.63%39.79M | 49.07%29.15M | 61.10%19.73M |
| Administration expense | 44.33%57.65M | 39.16%35.1M | 35.09%16.06M | 26.48%58.58M | 16.75%39.94M | 15.41%25.22M | 11.95%11.89M | 38.99%46.32M | 50.00%34.21M | 53.00%21.85M |
| Financial expense | 55.49%-5.5M | 55.79%-5.19M | 61.89%-2.8M | 31.63%-19.03M | 43.39%-12.35M | 14.81%-11.74M | -25.80%-7.35M | 15.49%-27.83M | 21.75%-21.81M | 29.20%-13.78M |
| -Interest expense (Financial expense) | 720.98%148.97K | --1.28K | --1.28K | 26.17%1.05M | -95.19%18.15K | ---- | ---- | 120.22%832.61K | 157.42%377K | 511.15%377K |
| -Interest Income (Financial expense) | 51.05%-5.53M | 49.56%-4.92M | 59.23%-2.63M | 39.40%-17.24M | 48.27%-11.3M | 29.11%-9.75M | 6.95%-6.45M | 4.36%-28.45M | 7.02%-21.85M | 19.55%-13.75M |
| Research and development | 29.93%223.58M | 32.76%147.72M | 36.45%69.74M | 26.49%241.97M | 18.77%172.07M | 18.68%111.27M | 9.84%51.11M | 28.74%191.29M | 32.30%144.87M | 39.49%93.75M |
| Credit Impairment Loss | 36.03%-2.28M | 73.04%-1.66M | 128.78%901.54K | 9.85%-4.68M | -64.66%-3.56M | -578.31%-6.15M | -429.44%-3.13M | -1.22%-5.19M | 58.85%-2.16M | 86.27%-905.98K |
| Asset Impairment Loss | -538.79%-83.23M | -516.64%-46.32M | -614.07%-8.3M | 96.69%-3.5M | 117.53%18.97M | 113.71%11.12M | 104.48%1.61M | -55.79%-105.83M | -3,173.05%-108.2M | -8,027.78%-81.11M |
| Other net revenue | ||||||||||
| Fair value change income | -17.17%-9.03M | 47.76%-9.03M | 95.66%-576.87K | -468.29%-34.87M | -186.46%-7.7M | -187.89%-17.28M | -166.62%-13.29M | -72.50%9.47M | -74.22%8.91M | --19.66M |
| Invest income | 10,380.78%9.43M | 10,380.78%9.43M | ---- | 6,306.93%39.53M | -85.41%90K | -54.88%90K | ---- | -45.33%617.04K | -24.73%617.04K | 33.83%199.48K |
| Other revenue | 193.33%38.89M | 249.63%19.63M | -98.01%106.9K | 387.08%45.25M | 366.91%13.26M | 205.80%5.61M | 2,426.81%5.38M | -56.79%9.29M | -57.81%2.84M | -46.16%1.84M |
| Operating profit | -79.88%47.71M | -74.94%36.3M | -63.63%18.59M | 537.21%305.38M | 311.11%237.19M | 268.98%144.86M | 269.75%51.11M | -184.92%-69.85M | -176.68%-112.35M | -178.65%-85.72M |
| Add:Non operating Income | ---- | ---- | ---- | 1,320.00%0.71 | 1,320.00%0.71 | 1,320.00%0.71 | --0.71 | -100.00%0.05 | -100.00%0.05 | -100.00%0.05 |
| Less:Non operating expense | -16.17%292.94K | -100.00%9.79 | -95.91%9.79 | 1,313.10%349.78K | 1,550.64%349.43K | 2,517.78%349.43K | -98.19%239.44 | -98.33%24.75K | -98.06%21.17K | -98.77%13.35K |
| Total profit | -79.98%47.42M | -74.88%36.3M | -63.63%18.59M | 536.56%305.03M | 310.76%236.84M | 268.55%144.51M | 269.68%51.11M | -186.50%-69.87M | -177.26%-112.37M | -179.44%-85.74M |
| Less:Income tax cost | -196.19%-11.63M | -152.04%-4.44M | -89.55%124.32K | 158.40%12.61M | 212.02%12.09M | 213.86%8.53M | 159.99%1.19M | -812.81%-21.6M | -249.21%-10.79M | -265.42%-7.49M |
| Net profit | -73.73%59.05M | -70.05%40.73M | -63.01%18.47M | 705.74%292.42M | 321.26%224.75M | 273.78%135.98M | 277.41%49.92M | -158.06%-48.27M | -173.50%-101.58M | -175.68%-78.25M |
| Net profit from continuing operation | -73.73%59.05M | -70.05%40.73M | -63.01%18.47M | 705.74%292.42M | 321.26%224.75M | 273.78%135.98M | 277.41%49.92M | -158.06%-48.27M | -173.50%-101.58M | -175.68%-78.25M |
| Net profit of parent company owners | -73.73%59.05M | -70.05%40.73M | -63.01%18.47M | 705.74%292.42M | 321.26%224.75M | 273.78%135.98M | 277.41%49.92M | -158.06%-48.27M | -173.50%-101.58M | -175.68%-78.25M |
| Earning per share | ||||||||||
| Basic earning per share | -69.08%0.47 | -60.87%0.36 | -63.83%0.17 | 704.35%2.78 | 258.33%1.52 | 224.32%0.92 | 223.68%0.47 | -141.82%-0.46 | -152.46%-0.96 | -154.01%-0.74 |
| Diluted earning per share | -69.08%0.47 | -60.44%0.36 | -63.83%0.17 | 700.00%2.76 | 258.33%1.52 | 222.97%0.91 | 227.03%0.47 | -141.82%-0.46 | -152.75%-0.96 | -154.41%-0.74 |
| Other composite income | ||||||||||
| Total composite income | -73.73%59.05M | -70.05%40.73M | -63.01%18.47M | 705.74%292.42M | 321.26%224.75M | 273.78%135.98M | 277.41%49.92M | -158.06%-48.27M | -173.50%-101.58M | -175.68%-78.25M |
| Total composite income of parent company owners | -73.73%59.05M | -70.05%40.73M | -63.01%18.47M | 705.74%292.42M | --224.75M | --135.98M | --49.92M | ---48.27M | ---- | ---- |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | -- | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.